According to GeneDx Holdings's latest financial reports the company's current EPS (TTM) is -$47.85. In 2022 the company made an earnings per share (EPS) of -$73.19 a decrease over its 2021 EPS that were of -$43.39.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$47.70 | -34.83% |
2022 | -$73.19 | 68.68% |
2021 | -$43.39 |